medigraphic.com
SPANISH

Acta Pediátrica de México

Órgano Oficial del Instituto Nacional de Pediatría
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2011, Number 3

<< Back Next >>

Acta Pediatr Mex 2011; 32 (3)

Use of masterly prescriptions cor children

Juárez-Olguín H
Full text How to cite this article

Language: Spanish
References: 5
Page: 175-176
PDF size: 209.15 Kb.


Key words:

No keywords

Text Extraction

No abstract


REFERENCES

  1. Flores Pérez C, Flores Pérez J, Juárez Olguín H, Barranco Garduño L. Frequency of drug consumption and lack of pediatric formulations. Acta Pediátr Méx 2008;29:16-20.

  2. McGinnity DF, Collington J, Austin RP, Riley RJ. Evaluation of human pharmacokinetic, therapeutic dose and exposure predictions using marketed oral drugs. Curr Drug Metab 2007;8:463-79.

  3. Juárez Olguín H, Flores Pérez C, Ramírez Mendiola B, Coria Jiménez R, Sandoval Ramírez E, Flores Pérez J. Extemporaneous suspension of propafenone. attending lack of pediatric formulations in Mexico. Pediatr Cardiol 2008;29:1077-81.

  4. Caldwell P, Murphy S, Butow P, Craig J. Clinical trials in children. Lancet 2004;364:803-11.

  5. Juárez Olguín H, Flores Pérez C, Ramírez Mendiola B, Barranco Garduño L, Sandoval Ramírez E, Flores Pérez J. Comparative bioavailability of propafenone between a magistral suspension vs. comercial tablets in healthy volunteers. Arzneim Forschung 2009;59:117-20.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Acta Pediatr Mex. 2011;32